Y-mAbs Therapeutics, Inc.·4

Dec 16, 6:05 PM ET

Rajah Vignesh 4

4 · Y-mAbs Therapeutics, Inc. · Filed Dec 16, 2021

Insider Transaction Report

Form 4
Period: 2021-12-14
Rajah Vignesh
SVP and CMO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-12-14+32,00032,000 total
    Exercise: $15.73Exp: 2031-12-14Common stock (32,000 underlying)
Footnotes (2)
  • [F1]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
  • [F2]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on December 14, 2022, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    tm2135463-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT